Retinal Vein Occlusion Flashcards
What is retinal vein occlusion (RVO)?
A blockage of the retinal veins, leading to impaired drainage of blood from the retina and potential vision loss.
What are the types of retinal vein occlusion?
Central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO).
What is the main cause of RVO?
Thrombosis or compression of the retinal vein, often associated with vascular risk factors.
What are the symptoms of CRVO?
Painless, sudden loss of vision or blurring in one eye, often worse in the morning.
What are the symptoms of BRVO?
Painless, sudden vision loss or blurring in part of the visual field, corresponding to the affected branch.
What is the pathophysiology of RVO?
Vein blockage causes increased venous pressure, leading to retinal haemorrhages, oedema, and ischaemia.
What are the risk factors for RVO?
Hypertension, diabetes, glaucoma, smoking, hyperlipidaemia, and thrombophilic conditions.
What are the characteristic fundoscopic findings in CRVO?
“Blood and thunder” appearance with retinal haemorrhages, optic disc oedema, and dilated tortuous veins.
What are the characteristic fundoscopic findings in BRVO?
Localised retinal haemorrhages and oedema along the affected vein branch.
What is macular oedema in RVO?
Swelling of the macula due to leakage from damaged retinal capillaries, causing central vision loss.
What are the complications of RVO?
Macular oedema, neovascularisation, vitreous haemorrhage, and neovascular glaucoma.
What investigations are used to confirm RVO?
Fundoscopy, optical coherence tomography (OCT), and fluorescein angiography.
What is the role of fluorescein angiography in RVO?
Identifies areas of ischaemia and leakage, guiding treatment decisions.
What is the conservative management of RVO?
Control of underlying risk factors such as hypertension, diabetes, and hyperlipidaemia.
What is the medical treatment for macular oedema in RVO?
Intravitreal anti-VEGF therapy (e.g., ranibizumab, aflibercept) or corticosteroids.